Regeneron and Roche are teaming up on an investigational antibody cocktail against COVID-19, with the U.S.
company to sell it in the United States and the Swiss drugmaker to sell it elsewhere, should the drug win approval. Leonard Schleifer, co-founder and chief executive of Regeneron, joins "Squawk Box" to discuss the initiative.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: